Safety and Efficacy of Eltrombopag Plus Pulsed Dexamethasone for Subjects With Idiopathic Thrombocytopenic Purpura

The Humanity & Health Medical Group Limited is overseeing a pilot study to assess whether twelve weeks of using eltrombopag and pulsed dexamethasone together can be used as ‘first-line’ therapy to evoke a sustained platelet count response in adults with ITP who have platelet counts below 30K microliters (or below 50K microliters with bleeding events). To be eligible to participate you must be an adult over 18 years of age, and you must not have tried any previous ITP therapies with the exception of a platelet transfusion.

Hong Kong

https://www.clinicaltrials.gov/ct2/show/NCT03830749?cond=Immune+Thrombocytopenia&draw=2&rank=44

Recruiting

back to top

BBB Cleveland logo GuideStar Seal NORD Member Badge 2018THSNA logo